Liz has over a decade of drug development experience in large pharma and small biotech, with expertise in developing protein therapeutics from discovery to early CMC. Throughout her career, she has focused on understanding protein structure and function relationships and the biophysical properties of therapeutic proteins. Most recently, she worked on immuno-oncology therapeutics in antibody discovery and protein analytics leading projects from candidate selection through initiation of GMP manufacturing and IND filing, giving her extensive experience in the drug development process. Liz brings this deep knowledge of protein therapeutics to her role as an Associate Scientific Director in the Translational Sciences group at Immunologix and as the head of the Immunologix Critical Reagents Group. Outside of Immunologix, she is a member of the American Association of Pharmaceutical Sciences and active in the Critical Reagents Subteam. Liz received her B.S. in chemistry from the College of William & Mary and her Ph.D. in Chemical Biology from the Scripps Research Institute.